Source: Kidney International Reports. Unidade: HU
Subjects: HEMODIÁLISE, GRANULOMA PIOGÊNICO
ABNT
CAIRES, Renato A et al. Topical Timolol in the Treatment of Hemodialysis Tunneled Catheter Exit-Site Pyogenic Granuloma. Kidney International Reports, v. 10, n. 4, p. 1296-1299, 2025Tradução . . Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC12034876/pdf/main.pdf. Acesso em: 13 fev. 2026.APA
Caires, R. A., Braun, D. A. S., Arakaki, W. G., Ventura, C. G., Di Nizo, F., Pegas, J. C. R., et al. (2025). Topical Timolol in the Treatment of Hemodialysis Tunneled Catheter Exit-Site Pyogenic Granuloma. Kidney International Reports, 10( 4), 1296-1299. doi:10.1016/j.ekir.2025.01.040NLM
Caires RA, Braun DAS, Arakaki WG, Ventura CG, Di Nizo F, Pegas JCR, Roque FL, Vieira Jr JM, Luders C. Topical Timolol in the Treatment of Hemodialysis Tunneled Catheter Exit-Site Pyogenic Granuloma [Internet]. Kidney International Reports. 2025 ; 10( 4): 1296-1299.[citado 2026 fev. 13 ] Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12034876/pdf/main.pdfVancouver
Caires RA, Braun DAS, Arakaki WG, Ventura CG, Di Nizo F, Pegas JCR, Roque FL, Vieira Jr JM, Luders C. Topical Timolol in the Treatment of Hemodialysis Tunneled Catheter Exit-Site Pyogenic Granuloma [Internet]. Kidney International Reports. 2025 ; 10( 4): 1296-1299.[citado 2026 fev. 13 ] Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12034876/pdf/main.pdf